AMERICAN VANGUARD CORP
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
AVD$0.82+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)
| For the Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(21,669) | $(35,911) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation of property, plant and equipment and amortization of intangible assets | 14,007 | 16,602 |
| Amortization of other long-term assets | 16 | 199 |
| Amortization and accretion of deferred loan fees and discounted liabilities | 1,167 | 342 |
| Gain on disposal of property, plant and equipment | (246) | — |
| Impairment of assets | 227 | — |
| Provision for estimated credit losses | 1,944 | 1,278 |
| Stock-based compensation | 1,741 | 3,887 |
| Change in deferred income taxes | (353) | (9,110) |
| Changes in liabilities for uncertain tax positions or unrecognized tax benefits | (522) | 106 |
| Change in equity investment fair value | 511 | (513) |
| Other | — | 110 |
| Unrealized foreign currency transactions (loss) gain | (704) | 121 |
| Changes in assets and liabilities associated with operations: | ||
| Decrease in net receivables | 935 | 33,475 |
| Increase in inventories | (16,513) | (29,429) |
| Increase in prepaid expenses and other assets | (965) | (4,107) |
| Change in income tax receivable/payable, net | (1,083) | (6,216) |
| Decrease in net operating lease liability | (150) | (48) |
| Increase in accounts payable | 11,859 | 14,512 |
| Decrease in customer prepayments | (21,453) | (38,375) |
| Increase in accrued program costs | 12,285 | 17,721 |
| (Decrease) increase in other payables and accrued expenses | (8,178) | 13,878 |
| Net cash used in operating activities | (27,144) | (21,478) |
| Cash flows from investing activities: | ||
| Capital expenditures | (2,398) | (6,106) |
| Proceeds from disposal of property, plant and equipment | 492 | 66 |
| Intangible assets | (136) | (341) |
| Net cash used in investing activities | (2,042) | (6,381) |
| Cash flows from financing activities: | ||
| Payments under line of credit agreement | (179,415) | (214,259) |
| Borrowings under line of credit agreement | 214,334 | 245,737 |
| Payment of deferred loan fees | (3,339) | — |
| Net receipt from the issuance of common stock under ESPP | 629 | 901 |
| Net payment for tax withholding on stock-based compensation awards | (147) | (1,416) |
| Payment of cash dividends | — | (2,510) |
| Net cash provided by financing activities | 32,062 | 28,453 |
| Net increase in cash and cash equivalents | 2,876 | 594 |
| Effect of exchange rate changes on cash and cash equivalents | 1,405 | (130) |
| Cash and cash equivalents at beginning of period | 12,514 | 11,416 |
| Cash and cash equivalents at end of period | $16,795 | $11,880 |
See notes to theunaudited Condensed Consolidated Financial Statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.